Importance of tumour cell invasion in blood and lymphatic vasculature among patients with endometrial carcinoma

Histopathology

Volumn 54, Issue 2, 2009, Pages 174-183

  Mannelqvist, Monica ^b   Stefansson, Ingunn ^b   Salvesen, Helga B ^a,c   Akslen, Lars A ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Blood vessel invasion; Endometrial cancer; Lymphatic vascular invasion; Metastasis; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD; CANCER GRADING; CANCER INVASION; CANCER SURVIVAL; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LONG TERM CARE; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; TUMOR GROWTH;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD31; BLOOD VESSELS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 58649096160     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2008.03201.x     Document Type: Article

References (28)

1. Prat J, Gallardo A, Cuatrecasas M, Catasus L. Endometrial carcinoma: pathology and genetics. Pathology 2007 39 72 87.
2. Creutzberg CL, van Putten WL, Koper PC et al. Survival after relapse in patients with endometrial cancer: results from a randomized trial. Gynecol. Oncol. 2003 89 201 209.
3. Andius P, Johansson SL, Holmang S. Prognostic factors in stage T1 bladder cancer: tumor pattern (solid or papillary) and vascular invasion more important than depth of invasion. Urology 2007 70 758 762.
4. Mohammed RA, Martin SG, Gill MS, Green AR, Paish EC, Ellis IO. Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences. Am. J. Surg. Pathol. 2007 31 1825 1833.
5. Ferrari MK, McNeal JE, Malhotra SM, Brooks JD. Vascular invasion predicts recurrence after radical prostatectomy: stratification of risk based on pathologic variables. Urology 2004 64 749 753.
6. Nagore E, Oliver V, Botella-Estrada R, Moreno-Picot S, Insa A, Fortea JM. Prognostic factors in localized invasive cutaneous melanoma: high value of mitotic rate, vascular invasion and microscopic satellitosis. Melanoma Res. 2005 15 169 177.
7. Stefansson IM, Salvesen HB, Immervoll H, Akslen LA. Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type. Histopathology 2004 44 472 479.
8. Straume O, Akslen LA. Independent prognostic importance of vascular invasion in nodular melanomas. Cancer 1996 78 1211 1219.
9. Akslen LA, Myking AO, Salvesen H, Varhaug JE. Prognostic importance of various clinicopathological features in papillary thyroid carcinoma. Eur. J. Cancer 1992 29A 44 51.
10. Gal D, Recio FO, Zamurovic D, Tancer ML. Lymphvascular space involvement - a prognostic indicator in endometrial adenocarcinoma. Gynecol. Oncol. 1991 42 142 145.
11. Hanson MB, van Nagell JR Jr., Powell DE et al. The prognostic significance of lymph-vascular space invasion in stage I endometrial cancer. Cancer 1985 55 1753 1757.
12. Inoue Y, Obata K, Abe K et al. The prognostic significance of vascular invasion by endometrial carcinoma. Cancer 1996 78 1447 1451.
13. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000 407 249 257.
14. Stefansson IM, Salvesen HB, Akslen LA. Vascular proliferation is important for clinical progress of endometrial cancer. Cancer Res. 2006 66 3303 3309.
15. Wong SY, Hynes RO. Tumor-lymphatic interactions in an activated stromal microenvironment. J. Cell. Biochem. 2007 101 840 850.
16. Stefansson IM, Salvesen HB, Akslen LA. Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer. J. Clin. Oncol. 2004 22 1242 1252.
17. Clark WH Jr., Elder DE, Guerry Dt et al. Model predicting survival in stage I melanoma based on tumor progression. J. Natl Cancer Inst. 1989 81 1893 1904.
18. Ambros RA, Kurman RJ. Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus. Cancer 1992 69 1424 1431.
19. Yamazawa K, Seki K, Matsui H, Sekiya S. Significance of perivascular lymphocytic infiltrates in endometrial carcinoma. Cancer 2001 91 1777 1784.
20. Abeler VM, Kjorstad KE. Endometrial adenocarcinoma in Norway. A study of a total population. Cancer 1991 67 3093 3103.
21. Kahn HJ, Marks A. A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab. Invest. 2002 82 1255 1257.
22. Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod. Pathol. 2002 15 434 440.
23. Fukunaga M. Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours. Histopathology 2005 46 396 402.
24. Sivridis E, Buckley CH, Fox H. The prognostic significance of lymphatic vascular space invasion in endometrial adenocarcinoma. Br. J. Obstet. Gynaecol. 1987 94 991 994.
25. Tsuruchi N, Kaku T, Kamura T et al. The prognostic significance of lymphovascular space invasion in endometrial cancer when conventional hemotoxylin and eosin staining is compared to immunohistochemical staining. Gynecol. Oncol. 1995 57 307 312.
26. Van den Eynden GG, Van der Auwera I, Van Laere SJ et al. Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study. Br. J. Cancer 2006 94 1643 1649.
27. Sakuragi N, Takeda N, Hareyama H et al. A multivariate analysis of blood vessel and lymph vessel invasion as predictors of ovarian and lymph node metastases in patients with cervical carcinoma. Cancer 2000 88 2578 2583.
28. Liang P, Nakada I, Hong JW et al. Prognostic significance of immunohistochemically detected blood and lymphatic vessel invasion in colorectal carcinoma: its impact on prognosis. Ann. Surg. Oncol. 2007 14 470 477.